The National Horsemen's Benevolent and Protective Association (HBPA) restated its strong support for the continued use of furosemide (marketed as Salix and commonly known as Lasix) at its summer convention Aug.15-17 in Oklahoma City, Oklahoma.

Furosemide is currently the only recognized treatment for exercise-induced pulmonary hemorrhage (EIPH).

The National HBPA joins the Thoroughbred Horsemen's Association, the Thoroughbred Owners of California, and the California Thoroughbred Trainers in supporting furosemide use in recent statements. Together these four horsemen's groups have nearly 50,000 owner and trainer members who race in the United States and Canada.

Those attending the Oklahoma City convention heard a panel of nationally recognized experts stating that current medical science does not support The Jockey Club's call for banning the race-day furosemide use. The HBPA says a ban would inevitably be harmful to horses